Pharmaceutical Excipients Market size to grow by USD 3,831.84 million from 2022 to 2027, Increasing demand for functional excipients to drive the market growth - Technavio

NEW YORK, April 24, 2023 /PRNewswire/ -- The global pharmaceutical excipients market size is estimated to increase by USD 3,831.84 million from 2022 to 2027. The market's growth momentum will be progressing at a CAGR of 6.54% during the forecast period. Increasing demand for functional excipients is driving market growth. Functional excipients are an integral part of the pharmaceutical industry. Demand for functional excipients is expected to grow rapidly during the forecast period due to their use in advanced drug delivery. Few companies focus on innovation in these additive categories using the latest technology while keeping standards. Several new formulations of certain generic drug ingredients are on the market. Advances in these drugs support controlled release and ease of consumption, especially in the form of orally dispersible tablets. In the future, nanotechnology and biotechnology may help change this field. Discover some insights on market size for Historic period (2017 to 2021) and the Forecast period 2023-2027 before buying the full report - Request a sample report

Pharmaceutical excipients market – Vendor Analysis
Vendor Landscape - The global pharmaceutical excipients market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer pharmaceutical excipients in the market are Actylis, Air Liquide SA, Archer Daniels Midland Co., Ashland Inc., Associated British Foods Plc, Avantor Inc., BASF SE, Colorcon Inc., Croda International Plc, DFE Pharma GmbH and Co. KG, Dow Inc., Evonik Industries AG, Innophos Holdings Inc., J M Huber Corp., JRS PHARMA GmbH and Co. KG, Kerry Group Plc, Merck and Co. Inc., Roquette Freres SA, The Lubrizol Corp., and Wacker Chemie AG and others.

What's New? -

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy Now!

Vendor Offerings -

• Archer Daniels Midland Co. - The company offers pharmaceutical excipients product solutions such as Hydrogenated Oils and Refined Olive Oil IV. 
• Ashland Inc. - The company offers pharmaceutical excipients product solutions such as Aquarius, Plasdone, and Viatel. 
• Associated British Foods Plc - The company offers pharmaceutical excipients product solutions such as Acconon Surfactants, Antacid Actives, and Digestive Aid Actives. 
• For details on the vendor and their offerings – Request a sample report

Pharmaceutical Excipients Market - Segmentation Assessment

Segment Overview
This report extensively covers market segmentation by type (organic and inorganic), product (binders and fillers, coating agents, disintegrants, and others), and geography (North America, Europe, APAC, South America, and Middle East and Africa). 

• The market share growth by the organic segment will be significant for the market growth during the forecast period. Excipients of organic origin include oleochemicals, carbohydrates, petrochemicals, proteins, etc. The most commonly used oleochemical-based pharmaceutical excipients are fatty alcohols, mineral stearates, and glycerin. Carbohydrate-based excipients include sugars, true sugars (lactose, sucrose, dextrose, etc.), sugar alcohols (sorbitol, mannitol, etc.), artificial sweeteners, cellulose (microcrystalline cellulose, cellulose ethers, carboxymethyl cellulose ( CMC), croscarmellose sodium, cellulose esters), starches (modified starches, dried starches, modified starches, etc.), and petrochemicals (glycols, etc.). Hence, the widespread use of organic pharmaceutical excipients in the pharmaceutical industry is expected to drive the growth of this market over the forecast period. 

Geography Overview
By geography, the global pharmaceutical excipients market is segmented into North America, Europe, APAC, South America, and Middle East and Africa. The report provides actionable insights and estimates the contribution of all regions to the growth of the global pharmaceutical excipients market.

• North America is estimated to account for 44% of the global market growth during the forecast period. The increasing aging population, rising healthcare costs, and high prevalence of chronic diseases such as diabetes and obesity are likely to boost the growth of the pharmaceutical industry in the region during the forecast period. For example, according to the 2020 Profile of Older Americans Report, the number of Americans aged 65 and over, increased from 39.6 million in 2009 to 54.1 million in 2019 (a 36% increase), and will grow to 94.7 million in 2060. The risk and complexity of chronic disease increases with age. Therefore, a wide range of pharmaceutical therapeutics is required to treat such diseases. Hence, such factors lead to the growth of the regional market during the forecast period.

To get some key insights on global, regional, and country-level market parameters with growth opportunities from 2017 to 2027 - Download a Sample Report

Pharmaceutical Excipients Market – Market Dynamics

Key Trends - 

• The growing demand for new excipients to develop easily ingested pharmaceuticals is a new trend in the market.
• The global market is primarily driven by increasing demand for orally available pharmaceuticals. The need to produce medicines that are easy to swallow, especially for the elderly and infants, primarily to improve patient comfort, plays a major role in forcing pharmaceutical manufacturers to produce easily-consumable tablets.
• This factor drives the development of new excipients in the pharmaceutical industry. Demand is also increasing for novel excipients, new chemically modified excipients, existing excipients with different routes of administration, and co-processed excipients.
• These excipients expand the scope of creating new formulations and drug delivery systems. 

Major challenges - 

• Reducing R&D costs is a major challenge hindering the growth of pharmaceutical excipients market. 
• Research and development efforts play an important role in the development of any industry.
• However, R&D investment in the market is currently declining, which will adversely affect market growth over the next five years. For example, Allergan Plc observed a decline in R&D spending from 2018 to 2019.
• The company spent around USD 2.2662 billion on R&D in 2018, while in 2019 the company spent about USD 1.812 billion in 2019.
• Declining research and development costs will make it more difficult to approve new production facilities. 

Driver, Trend & Challenges are the factor of market dynamics which states about consequences & sustainability of the businesses, find some insights from a sample report!

What are the key data covered in this Pharmaceutical Excipients Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the pharmaceutical excipients market between 2023 and 2027
• Precise estimation of the size of the pharmaceutical excipients market and its contribution to the market with a focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the pharmaceutical excipients market across North America, Europe, APAC, South America, and Middle East and Africa
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of the pharmaceutical excipients market vendors

To avail yourself instant lifetime access to 17,000+ market research reports, Subscribe to our Basic Plan billed annually at USD 5000. 

Technavio's SUBSCRIPTION platform

Related Reports:

The pharmaceutical cartridges market is estimated to grow at a CAGR of 6.32% between 2022 and 2027. The size of the market is forecast to increase by USD 540.18 million. This report extensively covers market segmentation by material (glass and plastic), capacity (below 5 ml, 5-50 ml, 51-250 ml, and above 250 ml), and geography (North America, Europe, Asia, and the Rest of World (ROW)). The increase in R&D spending in the pharmaceutical industry is notably driving the market growth. 

The pharma e-commerce market in Europe is estimated to grow at a CAGR of 15.47% between 2022 and 2027. The size of the market is forecast to increase by USD 16.42 billion. This report extensively covers market segmentation by type (Rx and OTC), and product (medications, health wellness and nutrition, and personal care and essentials). The omnichannel retailing technique by pharmacy chains is notably driving the market growth.

Browse for Technavio's Materials Reports

Table Of Contents : 

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global pharmaceutical excipients market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global pharmaceutical excipients market 2017 - 2021 ($ million)

• 4.2 Type Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ million)

• 4.3 Product Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type

• 6.3 Organic - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Organic - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Organic - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Organic - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Organic - Year-over-year growth 2022-2027 (%)

• 6.4 Inorganic - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Inorganic - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Inorganic - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Inorganic - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Inorganic - Year-over-year growth 2022-2027 (%)

• 6.5 Market opportunity by Type 
• Exhibit 42: Market opportunity by Type ($ million)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 43: Chart on Product - Market share 2022-2027 (%)
• Exhibit 44: Data Table on Product - Market share 2022-2027 (%)

• 7.2 Comparison by Product 
• Exhibit 45: Chart on Comparison by Product
• Exhibit 46: Data Table on Comparison by Product

• 7.3 Binders and fillers - Market size and forecast 2022-2027 
• Exhibit 47: Chart on Binders and fillers - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Data Table on Binders and fillers - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Chart on Binders and fillers - Year-over-year growth 2022-2027 (%)
• Exhibit 50: Data Table on Binders and fillers - Year-over-year growth 2022-2027 (%)

• 7.4 Coating agents - Market size and forecast 2022-2027 
• Exhibit 51: Chart on Coating agents - Market size and forecast 2022-2027 ($ million)
• Exhibit 52: Data Table on Coating agents - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Chart on Coating agents - Year-over-year growth 2022-2027 (%)
• Exhibit 54: Data Table on Coating agents - Year-over-year growth 2022-2027 (%)

• 7.5 Disintegrants - Market size and forecast 2022-2027 
• Exhibit 55: Chart on Disintegrants - Market size and forecast 2022-2027 ($ million)
• Exhibit 56: Data Table on Disintegrants - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Chart on Disintegrants - Year-over-year growth 2022-2027 (%)
• Exhibit 58: Data Table on Disintegrants - Year-over-year growth 2022-2027 (%)

• 7.6 Others - Market size and forecast 2022-2027 
• Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)

• 7.7 Market opportunity by Product 
• Exhibit 63: Market opportunity by Product ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 65: Chart on Market share by geography 2022-2027 (%)
• Exhibit 66: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 67: Chart on Geographic comparison
• Exhibit 68: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 APAC - Market size and forecast 2022-2027 
• Exhibit 77: Chart on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibit 78: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibit 79: Chart on APAC - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on APAC - Year-over-year growth 2022-2027 (%)

• 9.6 South America - Market size and forecast 2022-2027 
• Exhibit 81: Chart on South America - Market size and forecast 2022-2027 ($ million)
• Exhibit 82: Data Table on South America - Market size and forecast 2022-2027 ($ million)
• Exhibit 83: Chart on South America - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on South America - Year-over-year growth 2022-2027 (%)

• 9.7 Middle East and Africa - Market size and forecast 2022-2027 
• Exhibit 85: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibit 86: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibit 87: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)

• 9.8 UK - Market size and forecast 2022-2027 
• Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.9 US - Market size and forecast 2022-2027 
• Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.10 Germany - Market size and forecast 2022-2027 
• Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.11 Canada - Market size and forecast 2022-2027 
• Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.12 Japan - Market size and forecast 2022-2027 
• Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.13 Market opportunity by geography 
• Exhibit 109: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 112: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 114: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 115: Matrix on vendor position and classification

• 12.3 Archer Daniels Midland Co. 
• Exhibit 116: Archer Daniels Midland Co. - Overview
• Exhibit 117: Archer Daniels Midland Co. - Business segments
• Exhibit 118: Archer Daniels Midland Co. - Key offerings
• Exhibit 119: Archer Daniels Midland Co. - Segment focus

• 12.4 Ashland Inc.
• Exhibit 120: Ashland Inc. - Overview
• Exhibit 121: Ashland Inc. - Business segments
• Exhibit 122: Ashland Inc. - Key news
• Exhibit 123: Ashland Inc. - Key offerings
• Exhibit 124: Ashland Inc. - Segment focus

• 12.5 Associated British Foods Plc 
• Exhibit 125: Associated British Foods Plc - Overview
• Exhibit 126: Associated British Foods Plc - Business segments
• Exhibit 127: Associated British Foods Plc - Key offerings
• Exhibit 128: Associated British Foods Plc - Segment focus

• 12.6 Avantor Inc.
• Exhibit 129: Avantor Inc. - Overview
• Exhibit 130: Avantor Inc. - Business segments
• Exhibit 131: Avantor Inc. - Key offerings
• Exhibit 132: Avantor Inc. - Segment focus

• 12.7 BASF SE
• Exhibit 133: BASF SE - Overview
• Exhibit 134: BASF SE - Business segments
• Exhibit 135: BASF SE - Key news
• Exhibit 136: BASF SE - Key offerings
• Exhibit 137: BASF SE - Segment focus

• 12.8 Colorcon Inc.
• Exhibit 138: Colorcon Inc. - Overview
• Exhibit 139: Colorcon Inc. - Product / Service
• Exhibit 140: Colorcon Inc. - Key offerings

• 12.9 Croda International Plc 
• Exhibit 141: Croda International Plc - Overview
• Exhibit 142: Croda International Plc - Business segments
• Exhibit 143: Croda International Plc - Key news
• Exhibit 144: Croda International Plc - Key offerings
• Exhibit 145: Croda International Plc - Segment focus

• 12.10 DFE Pharma GmbH and Co. KG 
• Exhibit 146: DFE Pharma GmbH and Co. KG - Overview
• Exhibit 147: DFE Pharma GmbH and Co. KG - Product / Service
• Exhibit 148: DFE Pharma GmbH and Co. KG - Key offerings

• 12.11 Dow Inc.
• Exhibit 149: Dow Inc. - Overview
• Exhibit 150: Dow Inc. - Business segments
• Exhibit 151: Dow Inc. - Key news
• Exhibit 152: Dow Inc. - Key offerings
• Exhibit 153: Dow Inc. - Segment focus

• 12.12 Evonik Industries AG
• Exhibit 154: Evonik Industries AG - Overview
• Exhibit 155: Evonik Industries AG - Business segments
• Exhibit 156: Evonik Industries AG - Key news
• Exhibit 157: Evonik Industries AG - Key offerings
• Exhibit 158: Evonik Industries AG - Segment focus

• 12.13 Innophos Holdings Inc. 
• Exhibit 159: Innophos Holdings Inc. - Overview
• Exhibit 160: Innophos Holdings Inc. - Product / Service
• Exhibit 161: Innophos Holdings Inc. - Key offerings

• 12.14 Merck and Co. Inc.
• Exhibit 162: Merck and Co. Inc. - Overview
• Exhibit 163: Merck and Co. Inc. - Business segments
• Exhibit 164: Merck and Co. Inc. - Key news
• Exhibit 165: Merck and Co. Inc. - Key offerings
• Exhibit 166: Merck and Co. Inc. - Segment focus

• 12.15 Roquette Freres SA
• Exhibit 167: Roquette Freres SA - Overview
• Exhibit 168: Roquette Freres SA - Product / Service
• Exhibit 169: Roquette Freres SA - Key offerings

• 12.16 The Lubrizol Corp.
• Exhibit 170: The Lubrizol Corp. - Overview
• Exhibit 171: The Lubrizol Corp. - Product / Service
• Exhibit 172: The Lubrizol Corp. - Key offerings

• 12.17 Wacker Chemie AG
• Exhibit 173: Wacker Chemie AG - Overview
• Exhibit 174: Wacker Chemie AG - Business segments
• Exhibit 175: Wacker Chemie AG - Key offerings
• Exhibit 176: Wacker Chemie AG - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 177: Inclusions checklist
• Exhibit 178: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 179: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 180: Research methodology
• Exhibit 181: Validation techniques employed for market sizing
• Exhibit 182: Information sources

• 13.5 List of abbreviations 
• Exhibit 183: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio